|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-1-29
|
|
pubmed:abstractText |
The goal of this study was to determine the efficacy of intensive-course fluorouracil (5FU) plus low-dose leucovorin given for 6 months following potentially curative resection of colon cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
246-50
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8996149-Adult,
pubmed-meshheading:8996149-Aged,
pubmed-meshheading:8996149-Aged, 80 and over,
pubmed-meshheading:8996149-Antidotes,
pubmed-meshheading:8996149-Antimetabolites, Antineoplastic,
pubmed-meshheading:8996149-Chemotherapy, Adjuvant,
pubmed-meshheading:8996149-Colonic Neoplasms,
pubmed-meshheading:8996149-Female,
pubmed-meshheading:8996149-Fluorouracil,
pubmed-meshheading:8996149-Humans,
pubmed-meshheading:8996149-Leucovorin,
pubmed-meshheading:8996149-Male,
pubmed-meshheading:8996149-Middle Aged,
pubmed-meshheading:8996149-Neoplasm Staging,
pubmed-meshheading:8996149-Proportional Hazards Models,
pubmed-meshheading:8996149-Prospective Studies,
pubmed-meshheading:8996149-Recurrence,
pubmed-meshheading:8996149-Risk Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
|
|
pubmed:affiliation |
North Central Cancer Treatment Group, Rochester, MN, USA. oconnell.michael@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
